RAFAEL HOLDINGS, INC. Investment Income, Interest
RAFAEL HOLDINGS, INC. (RFL) reported Investment Income, Interest of $188.00 thousand for the 3-month period ending 2021-10-31, per its 10-Q filed 2022-12-13.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2022-12-13
- RAFAEL HOLDINGS, INC. investment income, interest for the quarter ending 2021-10-31 was $188.00K.
| Period end | Investment Income, Interest 3 month |
|---|---|
| 2021-10-31 | $188.00K 10-Q · filed 2022-12-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |